[DNLI] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 15.04%
YoY- 8.71%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 10,283 3,559 52,480 42,141 12,514 5,285 22,939 -41.34%
PBT -98,684 -103,299 -58,767 -65,220 -75,836 -84,588 -60,691 38.15%
Tax -6 2,114 27 -1,278 -575 782 728 -
NP -98,678 -103,299 -58,794 -63,942 -75,261 -84,588 -60,691 38.14%
Tax Rate - - - - - - - -
Total Cost 108,961 106,858 111,274 106,083 87,775 89,873 83,630 19.23%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -959.62 -2,902.47 -112.03 -151.73 -601.41 -1,600.53 -264.58 135.50%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.74 -0.84 -0.48 -0.52 -0.62 -0.69 -0.50 29.77%
EPS Diluted -0.74 -0.84 -0.48 -0.52 -0.62 -0.69 -0.49 31.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.